Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Product Liability

Last week, the FDA said it had received reports of six new cases of pancreatitis – including two deaths – associated with the diabetes drug Byetta. Today, Amylin and Eli Lilly said that they had reported four additional deaths to the agency as well, which the FDA hasn’t yet made public.

The companies, which co-market the drug, chose to disclose the additional information in order to “provide context” about each of the cases, according to Amylin President and Chief Executive Daniel Bradbury.

Continue reading

Duragesic brand and generic fentanyl pain patches have been associated with cases of overdose and death. Poor design, inadequate warnings and poor quality controls during the manufacturing process could result in excessive amounts of fentanyl entering the body.

Lawsuits have been filed throughout the United States for users who have died or become comatosed from a fentanyl overdose.

Continue reading

Mesothelioma is a rare form of lung cancer caused by exposure to asbestos and breathing asbestos fibers. It is a very serious disease, which is often at a very advanced stage when a diagnosis is made. The disease is uniformally fatal. The first asbestos lawsuit was filed in 1929, and with thousands of people being diagnosed with this condition each year.

Mesothelioma is almost always caused by exposure to asbestos either directly or indirectly through family members who worked with the material. A mesothelioma cancer diagnosis can be made years after a family member carried home asbestos dust or fibers on their clothing, shoes, skin or in their hair.

Continue reading

The FDA today said it plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other hospitalizations in Byetta users.

Those patients had hemorrhagic pancreatitis (inflammation of the pancreas with bleeding) or necrotizing pancreatitis (in which the inflamed pancreas destroys itself).

All six patients were hospitalized, and their Byetta treatment was stopped. The four survivors were still recovering at the time that the FDA learned of their illness.

Byetta and other potentially suspect drugs should be promptly discontinued if pancreatitis is suspected and not restarted if pancreatitis is confirmed, notes the FDA. Byetta, given by injection, was approved by the FDA in 2005.

Continue reading

Byetta is an injectable therapy to improve blood sugar control in patients with Type II diabetes, which is most often prescribed for patients who have not been able to achieve adequate control on metformin and/or a sulfonylurea, two often prescribed diabetes medications that are taken orally. Byetta has been prescribed alone or in conjunction with other diabetes medicines.

Byetta has side effects that can be harmful. October 2007, the FDA first warned that Byetta may cause acute pancreatitis and reviewed 30 reports of pancreatitis. On August 18, 2008, the FDA announced that the Agency has received six new reports of patients developing severe hemorrhagic or necrotizing pancreatitis. All cases required hospitalization, with two patients dead and four still in recovery.

Continue reading

A California man, filed a personal injury claim against Yamaha Motor Corporation in California Superior Court. The lawsuit alleged that the Yamaha Rhino side-by-side is a dangerously unstable and defective all terrain vehicle.

In 2006, the 42 years old, was a passenger in a 2006 Yamaha Rhino when it tipped over at a low rate of speed. The man suffered severe crush injuries to his right leg from the roll bar and was left permanently damaged.

Continue reading

Actavis Totowa a New Jersey based company, earlier in the year started a nationwide recall of all strengths of the Digitek pills, which are distributed by Mylan Pharmaceuticals Inc. and UDL Laboratories Inc.

The maker of the heart drug Digitek faces several federal lawsuits in New Jersey, including one where a patient died, alleging the drug was dangerous and defective.

Continue reading

Two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are currently being investigated throughout the country by individuals who are trying to determine if they may be entitled to compensation through a Digitek lawsuit.

Many people have described problems that surfaced during the months around the recall, but some have reported problems consistent with a Digitek overdose as early as 2006. Since the manufacturer has released very little information about the extent of the Digitek problems, all cases are being reviewed to determine if injuries could have caused by the manufacturing problems.

Continue reading

Public Citizen, a consumer advocacy group petitioned the FDA to pull the birth control patch, Ortho-Evra off the market, warning that it was far riskier than the pill.

Complaints about the Ortho-Evra weekly patch have risen since a 2005 investigation by The Associated Press found that patch users had higher rates of life-threatening blood clots than did women who took birth control pills.

Continue reading

Chantix the anti smoking drug, has been linked to an increased risk of psychiatric and mental health problems including suicides, suicide attempts, aggressive and unusual behavior. The FDA has received many reports involving serious and sometimes fatal injuries linked to Chantix to psychiatric side effects.

Lawsuits have been filed on behalf of individuals who died or suffered severe physical injury as a result of a suicide, suicide attempt or suddent unusual behavior.

Continue reading

Contact Information